Urocit-K

Urocit-K is a brand name of potassium citrate, approved by the FDA in the following formulation(s):

UROCIT-K (potassium citrate - tablet, extended release; oral)

• 
  Manufacturer: MISSION PHARMA
  
  Approval date: August 30, 1985
  
  Strength(s): 5MEQ ^[AB]


• 
  Manufacturer: MISSION PHARMA
  
  Approval date: August 31, 1992
  
  Strength(s): 10MEQ ^[AB]


• 
  Manufacturer: MISSION PHARMA
  
  Approval date: December 30, 2009
  
  Strength(s): 15MEQ ^[RLD]

Has a generic version of Urocit-K been approved?

Yes. The following products are equivalent to Urocit-K:

potassium citrate tablet, extended release; oral

• 
  Manufacturer: COREPHARMA
  
  Approval date: June 9, 2006
  
  Strength(s): 10MEQ ^[AB], 5MEQ ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Urocit-K. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Urocit-K.

See also...

• Urocit-K Consumer Information (Wolters Kluwer)
• Urocit-K Consumer Information (Cerner Multum)
• Potassium Consumer Information (Drugs.com)
• Potassium Citrate Consumer Information (Wolters Kluwer)
• Potassium citrate Consumer Information (Cerner Multum)
• Urocit-K 10 Oral Advanced Consumer Information (Micromedex)
• Urocit-K 15 Oral Advanced Consumer Information (Micromedex)
• Urocit-K 5 Oral Advanced Consumer Information (Micromedex)
• Potassium citrate Advanced Consumer Information (Micromedex)